glp-1 news today october 16 2025 Rising use of medications among women with PCOS Eli Lilly, Novo Nordisk Strike

At the same time, both Lilly and Novo Nordisk made multi-billion dollar capital investments in expanding their manufacturing capacity to satisfy unrelenting patient demand, including pharmas largest M&A deal of the year, the $16.5Bn acquisition of CDMO Catalent by Novo Holdings, the controlling shareholder of Novo Nordisk

Recent evidence from the STEP-HFpEF and STEP-HFpEF-DM trials provides the first robust data supporting the efficacy of GLP-1 RAs, specifically semaglutide, in improving the quality of life in obese patients with HFpEF

Blood was sampled throughout the day for analysis of plasma hormone and substrate concentrations

The honest answer is nothing, until you make it do something

Furthermore, Covid-19 may induce substantial alterations in gut microbiota

What does the Eli Lilly compounding lawsuit dismissal mean for the GLP-1 market